The Sacramento Bee reports on progress, sort of, for the California Institute for Regenerative Medicine: the first grants have been declared, but "the money comes in the form of an 'IOU' because bond sales to pay for the research are tied up in litigation. Robert Klein, chairman of the California Institute for Regenerative Medicine governing board, said the grantees are encouraged to begin their programs now if they have the money, with the promise of reimbursement later. The award winners, not surprisingly, include research heavies such as UCLA, Stanford University, UC San Diego and UC San Francisco." The wasteful battle over funding embryonic stem cell research and stalling of actual money awards looks to continue into next year at the current rate - par for the course for public programs.
Link: http://www.sacbee.com/content/politics/story/13543609p-14383968c.html